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Abstract: Liposuction is the most popular aesthetic surgery performed in Brazil and worldwide. 
Evidence showing that adipose tissue is a metabolically active tissue has led to the suggestion 
that liposuction could be a viable method for improving metabolic profile through the immediate 
loss of adipose tissue. However, the immediate liposuction-induced increase in the proportion 
of visceral to subcutaneous adipose tissue could be detrimental to metabolism, because a high 
proportion of visceral to subcutaneous adipose tissue is associated with risk factors for cardio-
vascular disease. The results of studies investigating the effects of liposuction on the metabolic 
profile are inconsistent, however, with most studies reporting either no change or improvements 
in one or more cardiovascular risk factors. In addition, animal studies have demonstrated a com-
pensatory growth of intact adipose tissue in response to lipectomy, although studies with humans 
have reported inconsistent results. Exercise training improves insulin sensitivity, inflammatory 
balance, lipid oxidation, and adipose tissue distribution; increases or preserves the fat-free mass; 
and increases total energy expenditure. Thus, liposuction and exercise appear to directly affect 
metabolism in similar ways, which suggests a possible interaction between these two strategies. 
To our knowledge, no studies have reported the associated effects of liposuction and exercise in 
humans. Nonetheless, one could suggest that exercise training associated with liposuction could 
attenuate or even block the possible compensatory fat deposition in intact depots or regrowth 
of the fat mass and exert an additive or even a synergistic effect to liposuction on improving 
insulin sensitivity and the inflammatory balance, resulting in an improvement of cardiovascular 
risk factors. Consequently, one could suggest that liposuction and exercise appear to be safe and 
effective strategies for either the treatment of metabolic disorders or aesthetic purposes.
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Introduction
The idea of the surgical removal of body fat mass from specific regions of the body is 
not recent. The first attempt was performed in France in 1921, when Charles   Dujarrier 
removed the subcutaneous fat of the calves and knees of a female dancer using a 
  uterine curette. The disastrous outcome was the amputation of the dancer’s leg.   During 
subsequent years, other physicists and scientists developed different techniques to 
remove subcutaneous body fat. However, all of these techniques resulted in undesir-
able hematomas and/or scars.1
The field of modern liposuction was initiated in 1974 by Arpad and Giuliano Fischer 
in Italy. It was only in 1987, however, that Jeffrey Klein innovated the field by develop-
ing the tumescent technique, which eliminated the high risk of excessive bleeding that 
is usually observed during liposuction surgeries, making it a much safer procedure.2 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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The development of the tumescent technique allowed 
the removal of greater amounts of fat in a much safer 
  environment. This innovation, together with the knowledge 
that adipose tissue is a very metabolically active organ,3 led 
scientists to believe that liposuction could be a viable method 
for improving metabolic profile through the immediate loss 
of body fat mass, thus functioning as a possible coadjuvant 
in the treatment of obesity and comorbidities.4
The beneficial effects of exercise are well known. 
  Evidence from epidemiologic and experimental studies has 
shown that regular exercise protects against the development 
and progression of numerous diseases such as heart diseases, 
diabetes, and obesity.5,6 In addition, exercise training directly 
affects the body composition, preserving or increasing fat-free 
mass7 and stimulating fat mass loss,6 in addition to improving 
inflammatory balance8,9 and insulin sensitivity.10
The combination of both strategies could therefore 
enhance the loss and/or maintenance of body fat mass for 
health or aesthetic purposes, in addition to potentially lead-
ing to greater beneficial effects in the treatment of metabolic 
disorders through improving metabolic profile (insulin sen-
sitivity and lipid profile) and inflammatory balance.
The aim of this paper is to briefly characterize adipose 
tissue, review the distinct effects of exercise and liposuction, 
and suggest possible combined effects of both fat-loss strate-
gies in adiposity and metabolism.
Adipose tissue
Adipose tissue is a remarkable and very efficient energy storage 
organ that is composed of adipocytes. The adipocyte is a unique 
cell. It stores triglycerides (TAGs) in a single lipid droplet 
that accounts for approximately 90% of the cell mass.3 When 
energy intake is abundant, excess TAGs are stored in adipose 
tissue to be mobilized during periods of energy deficit. TAGs 
can be incorporated into adipocytes through the uptake of fatty 
acids (FAs) from circulating lipoprotein   (chylomicrons or very 
low-density lipoprotein [VLDL]) or can be synthesized during a 
process called lipogenesis.11 In periods of energy deficit, stored 
TAGs are mobilized in a process called lipolysis that results 
in the release of free fatty acids (FFAs) into the circulation. 
These FFAs can be captured by other tissues for oxidation in 
the mitochondria through the process of b-oxidation and used 
as substrate for energy production.3,11
The expansion of adipose tissue in response to weight 
gain seems to depend first on adipocyte hypertrophy.12 In 
fact, the adipocyte has a remarkable storage capacity and is 
capable of large changes in its TAG volume, with cell sizes 
ranging from 25 µm to 200 µm in diameter.5 However, as the 
need for lipid storage increases, preadipocytes are recruited 
and differentiate into adipocytes in a process called adipo-
genesis, which consists of adipocyte hyperplasia.11
Adipogenesis is the process by which undifferenti-
ated   fibroblast-like preadipocytes differentiate into mature 
adipocytes.12,13 It occurs in several stages and can be 
described as a cascade of gene expression that is regulated 
by a small set of transcription factors.14,15 Two transcription 
factor families appear to be the key determinants of terminal 
adipocyte differentiation: peroxisome proliferator-activated 
receptor gamma (PPARγ) and CCAATT/enhancer-binding 
proteins (C/EBPs).13,14
As cells undergo the differentiation process in response 
to stimulating signals, the initial stage is the induction of 
C/EBPb and C/EBPδ expression.14,15 These transcription fac-
tors activate the following stage, which includes the increase 
in the major adipogenic transcription factors C/EBPα and 
PPARγ. C/EBPα and PPARγ then induce their own expres-
sion in addition to each other’s expression,15 acting syner-
gistically to generate fully differentiated insulin-responsive 
adipocytes.14 During the terminal stage of differentiation, 
there is an increase in the protein and mRNA levels of 
enzymes, receptors, and transporters involved in lipogen-
esis, lipolysis, and insulin-mediated glucose uptake and of 
  adipokines.12 It is important to highlight that although PPARγ 
is essential and sufficient for induction of the expression of 
many adipocyte genes, C/EBPα is required to confer insulin 
sensitivity to the adipocyte.13–15 Emerging additional factors 
also play regulatory roles in the process of adipogenesis, such 
as ADD1/SREBP1, STAT proteins, Kruppel-like factors, 
wingless INT-1 proteins, cell-cycle proteins, and GATA-
binding protein-2 and -3.12,13,16 Whether these factors target 
similar sets of genes as C/EBPs and PPARγ or enhance or 
antagonize their effects still remains to be determined.13
The processes of adipogenesis, lipogenesis, and lipolysis 
are tightly regulated by nutrients and neurohumoral signal-
ing in response to the energy needs of the individual,3 thus 
maintaining energy homeostasis. Insulin is the major hor-
mone stimulating lipogenesis and adipogenesis, in addition 
to inhibiting lipolysis. On the other hand, catecholamines are 
the most potent regulators of lipolysis in humans,17 although 
glucagon, growth hormone, and thyroid hormones also 
stimulate lypolysis.3
Adipokines and insulin sensitivity
The remaining 10% of the adipocyte cell mass has a remark-
able secretory ability, synthesizing and releasing many auto-
crine, paracrine, and endocrine factors called adipokines.18 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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A few of these adipokines might not be produced by the 
adipose tissue itself but by macrophages that have infil-
trated the adipose tissues.5 Adipocytes also express several 
receptors that enable them to respond to neurohumoral and 
hormonal signals. Therefore, adipose tissue constantly com-
municates with several organs, including the central nervous 
system (CNS).18 Through this dynamic signaling network, 
adipose tissue and adipokines participate in important bio-
logic processes such as energy intake and energy balance, 
nutrient metabolism, and the immune system.8,18,19
Adipokines such as leptin, adiponectin, tumor necrosis 
factor (TNF)-α, interleukin (IL)-6, and IL-10 play a funda-
mental role in energy metabolism, insulin sensitivity, and 
the inflammatory balance20 and will be briefly discussed in 
this review.
Leptin is an ob gene product and is known as the “satiety 
hormone”. Its levels and expression are highly correlated 
to the amount of body fat mass.17,21,22 The central role of 
leptin is to signal the fat mass status to the CNS. It acts on 
hypothalamic neurons to inhibit food intake and enhance 
energy expenditure and sympathetic nervous system (SNS) 
activity.23 Evidence also suggests an important peripheral role 
of leptin. In addition to stimulating the SNS, leptin impairs 
the effects of insulin on adipose tissue and increases TNF-α 
secretion, both of which lead to increased lipolysis.22,24 
Moreover, it enhances the function and sensitivity of insulin 
in skeletal muscle by increasing FFAs and glucose oxida-
tion via activation of 5′-adenosine monophosphate-activated 
protein kinase.22,24,25
Leptin mRNA is elevated in subcutaneous adipose tissue 
(SAT) compared with visceral adipose tissue (VAT), probably 
because subcutaneous adipocytes are larger than omental 
adipocytes, and as adipocytes increase in size, leptin mRNA 
is upregulated.26 Other factors also regulate leptin expression, 
synthesis, and secretion. Insulin, glucose, glucocorticoids, 
and TNF-α appear to stimulate leptin secretion, whereas 
sympathetic and adrenergic stimulation, growth hormone, 
thyroid hormones, androgens, and melatonin appear to reduce 
leptin levels.3,21 Subtle disturbances in the energy balance also 
affect the expression and synthesis of leptin. An increase or 
a decrease in energy intake without changes in body weight 
results in a keen decrease and increase, respectively, in leptin 
levels within 12 hours.27 Thus, leptin can be considered as a 
sensor of the energy balance.28
Adiponectin is synthesized and secreted mostly by 
the adipose tissue. Its levels are inversely correlated to 
the amount of body fat mass11 and risk of insulin resistance 
and cardiovascular diseases.3 In fact, adiponectin levels are 
reduced in obese, insulin-resistant, and diabetic individuals 
and appear to increase after weight and fat loss in obese 
people.28 Its metabolic effects include a reduction of hepatic 
lipid and glucose synthesis, leading to reduced levels of cir-
culating glucose and FFAs, in addition to increasing glucose 
uptake and glucose and FA oxidation in the skeletal muscle 
and adipose tissue. All of these actions will ultimately lead to 
improved insulin sensitivity.3,19,28 Additionally, adiponectin 
has an anti-inflammatory and an antiatherogenic effect. It 
reduces the synthesis of proinflammatory cytokines such 
as TNF-α and C-reactive protein (CRP), enhances vasodi-
latation, inhibits the adhesion of monocytes to the vascular 
endothelium, and suppresses the transformation of mac-
rophages into foam cells (the latter are essential steps in the 
development of vascular diseases).3,19
TNF-α is an immunomodulatory and proinflammatory 
cytokine3 that is produced by a variety of cell types. It is 
produced mainly by cells of the immune system (monocytes, 
macrophages, and lymphocytes) but also by tumor cells, 
smooth muscle cells, fibroblasts, and, to a lesser extent, 
adipocytes.29,30 The correlation between plasma TNF-α and 
adiposity is relatively weak, which suggests that TNF-α 
produced in adipose tissue acts primarily in a paracrine and 
autocrine manner.17,31 Nevertheless, its levels are higher 
in obesity and decrease after weight and fat loss,3,17,29 and 
its expression and secretion in adipose tissue appear to be 
elevated in obese subjects.3,17 More importantly, TNF-α is an 
important inducer of insulin resistance in the liver, adipose 
tissue, and skeletal muscle.3,29 It is likely that TNF-α impairs 
the activity of insulin via the suppression of insulin signal-
ing and the translocation of glucose transporter 4 (GLUT-4) 
to the membrane.11,31 In addition, it decreases the levels of 
adiponectin and increases those of cytokines such as IL-6, 
IL-1, and leptin.31,32 In adipose tissue, TNF-α also inhibits 
lipogenesis and adipogenesis and enhances lipolysis, which 
increases the amount of FFAs in the circulation. This could 
also impair the activity of insulin.3,30 It has been demonstrated 
in vitro that TNF-α is a major factor in the regulation of 
adipocyte number. It inhibits the differentiation of new adipo-
cytes and promotes dedifferentiation or induces apoptosis of 
existing adipocytes or preadipocytes.31 It has been suggested 
that the production of TNF-α by adipose tissue could be a 
local regulator of fat cell size and that the overproduction of 
TNF-α in adipocytes of obese individuals could be a homeo-
static mechanism that is designed to limit further increases 
in adipocyte size.17 Altogether, the net effect of TNF-α is to 
induce insulin resistance, increase lipid mobilization, and 
facilitate a proinflammatory state.32Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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IL-6 is also produced by many cell types, such as 
  monocytes, fibroblasts, and endothelial cells.29 However, 
in contrast to TNF-α, IL-6 plasma levels are proportional 
to the fat mass and increase in obesity, suggesting that 
adipose tissue may be an important source of circulating 
IL-6 levels in the absence of acute inflammation.17,29 In fact, 
adipocytes contribute to approximately 35% of the circu-
lating IL-6 levels.8 IL-6 synthesis is stimulated by TNF-α, 
and these cytokines have many similar effects. They are 
both immunomodulatory and proinflammatory cytokines 
that stimulate lipid mobilization and insulin resistance.29,31 
In addition, IL-6 may further decrease insulin sensitivity 
by reducing the secretion of adiponectin.8 IL-6 appears to 
play a more systemic role than TNF-α; it induces hepatic 
CRP release and has anorectic effects on the hypothalamus, 
similarly to leptin.31 In fact, elevated IL-6 and CRP plasma 
levels are predictive of the development of diabetes and 
cardiovascular disease.29,33
IL-10 is a potent anti-inflammatory cytokine that is also 
produced by many cell types, including monocytes, mac-
rophages, and lymphocytes.30 IL-10 is a potent inhibitor of 
the production of proinflammatory cytokines and chemokines 
implicated and involved in the onset of inflammation. Its anti-
inflammatory activities rely mostly on the inhibition of IL-1 
and TNF-α synthesis from a variety of cell types and on the 
stimulation of expression of their natural antagonists (IL-1RA 
and soluble TNF receptor), thus enhancing the synthesis 
of anti-inflammatory molecules.34 IL-10 is also expressed 
and secreted by adipose tissue, and its circulating levels are 
elevated in obese subjects30 and during acute inflammation,31,35 
which suggests that IL-10 may act as a feedback mechanism 
in response to the excess secretion of proinflammatory cytok-
ines such as TNF-α,36,37 possibly in an attempt to attenuate its 
deleterious proinflammatory effects.30
Adipose tissue distribution
There are two main depots of adipose tissue in the body, 
SAT and VAT, and they differ in anatomic location and 
metabolic function.
The expression and secretion of adipokines in adipose 
tissue vary according to the adipocyte size and number and 
to the adipose tissue depot.3,17,22,29–31 IL-6 secretion is higher 
in VAT than in SAT,17,29,30,38 which could partly explain the 
relationship between abdominal obesity and cardiovascular 
risk in humans.29 On the other hand, adiponectin expression 
and secretion, as well as leptin expression,17,22,29 are higher 
in SAT than in VAT adipocytes,17,29,30 probably due to differ-
ences in the fat cell size. The larger the adipocyte, the greater 
the expression of leptin.22 TNF-α appears to be expressed 
and secreted equally in both depots.17
Lipid mobilization and subsequent FFA and glycerol 
release are modulated by the SNS17 and differ greatly in SAT 
and VAT. Catecholamines are the most potent regulators 
of lipid mobilization in adipose tissue via the stimulation 
of adrenoreceptors (b1-, b2-, and b3-adrenoreceptors) and 
the inhibition of α2-adrenoreceptors.3,39 b-adrenoreceptors 
stimulate hormone-sensitive lipase (HSL) and inhibit lipo-
protein lipase, which leads to increased lipolysis, whereas 
α2-adrenoreceptors have the opposite effect.17 Insulin, on the 
other hand, has a lipogenic effect that favors TAG deposition 
in adipose tissue via the stimulation of adipogenesis, glucose 
and FFA uptake, and TAG synthesis within adipocytes. In 
addition, insulin stimulates α2-adrenoreceptors.40
Femoral and gluteal subcutaneous adipocytes display a 
lower lipolytic response to catecholamine than abdominal 
subcutaneous adipocytes and an even lower response than 
visceral adipocytes. These differences can be explained by 
a variation in adrenoreceptor density and sensitivity among 
these adipocytes. Abdominal SAT shows increased b1- and 
b2-adrenoreceptors and decreased α2-adrenoreceptors when 
compared with femoral and gluteal SAT.39 VAT adipocytes are 
even more sensitive than abdominal SAT to catecholamine-
induced lipolysis and are less sensitive to insulin activity, pre-
senting a greater number of b1-, b2-, and b3-adrenoreceptors 
with enhanced sensitivity.17 Thus, VAT is considered to be 
more metabolically active, and it presents lipolysis rates that 
are up to 50% higher than those of SAT.38
The enhanced lipolytic activity in VAT may lead to 
increased FFA levels in the systemic circulation. Because 
VAT is drained by the portal venal system, increased amounts 
of VAT may lead to an increased delivery of FFAs to the liver. 
This could lead to increased VLDL production and secretion, 
in addition to the induction of changes in insulin signaling 
that may culminate in increased glucose production due to 
a decreased inhibition of hepatic glucose output. This cre-
ates a favorable environment for the onset of dyslipidemia, 
glucose intolerance, and hyperinsulinemia.17,41 In addition 
to the effects on the liver, increased FFA levels impair 
insulin signaling in the skeletal muscle, thus decreasing 
insulin-mediated glucose uptake and consequently leading 
to hyperglycemia.38 This, in turn, could potentiate glucose-
stimulated insulin production and therefore contribute to a 
state of hyperinsulinemia and insulin resistance.41
It has been suggested that the distribution of body 
fat is more important for cardiovascular risk than total 
  adiposity. Upper-body fat, especially fat in the visceral area, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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is   independently associated with several risk factors for 
metabolic and   cardiovascular complications (coronary artery 
disease, hyperinsulinemia, insulin resistance, hypertension, 
and dyslipidemia).17,41–45 According to Kral,46 SAT, especially 
gluteofemoral SAT, may function as a “metabolic sink” that 
accommodates excess energy intake through the uptake of 
excess FFAs, which could impair glucose uptake and insulin 
sensitivity. However, according to Kelley et al,38 not only 
VAT but also deep abdominal SAT may have a significant 
metabolic role. The authors show that, similarly to VAT, 
abdominal deep SAT displays a robust relation to insulin 
resistance and other cardiovascular risk factors, such as 
blood pressure, fasting insulin, and lipids. The authors note, 
however, that abdominal superficial SAT shows a weak 
association with insulin resistance, following the pattern of 
gluteofemoral SAT.38 It has also been suggested that upper-
body SAT may be the predominant source of circulating 
FFAs, because SAT is reasonably larger than VAT and is 
therefore able to release more FFAs into the circulation.17,41 
However, excess visceral fat is still considered an indepen-
dent risk factor that links central fat and insulin resistance. 
This association is partly due to the molecules that are 
released, such as IL-6, which play a significant role in insulin 
sensitivity.17 Therefore, one could affirm that increased VAT 
is a very powerful risk factor for the development of cardio-
vascular diseases, with an even greater risk encountered in 
the presence of increased deep abdominal SAT.
Liposuction
Liposuction is the most popular aesthetic surgery performed 
worldwide.47 The Brazilian Society of Plastic Surgery esti-
mates that approximately 92,000 liposuction surgeries are 
performed every year in Brazil, which represents 20% of all 
aesthetic plastic surgeries. In the US, liposuction is also the 
most frequent aesthetic surgery performed each year.48
The American Academy of Cosmetic Surgery49 recom-
mends that liposuction should only be indicated for the 
removal of localized deposits of adipose tissue that do not 
respond to diet and exercise and should not be indicated for 
weight loss purposes. Thus, ideal candidates for surgery 
would be healthy individuals who are in good physical con-
dition (within 30% of ideal weight).48 Prior to liposuction, 
the physician infuses the body with a determined volume of 
buffered saline solution. Depending on the volume of this 
infusion, the surgery is considered a small-volume liposuc-
tion (,5 L) or a large-volume liposuction (.5 L).50 Small-
volume liposuction is the most safe and commonly performed 
procedure in normal to overweight individuals.51
Nevertheless, in light of the possible benefits of this 
surgery on the metabolic profile, large-volume liposuction 
has frequently been performed in obese people, especially 
for scientific purposes.
effects of liposuction on the metabolic 
profile
Because adipose tissue is clearly a complex, metabolically 
active organ, its instant removal by liposuction could directly 
affect metabolism in obese and nonobese individuals.51 In 
general, studies concerning the metabolic effects of liposuc-
tion are controversial.
VAT remains intact during liposuction, in contrast to SAT. 
Because of the possible beneficial effects of SAT described 
previously, a few authors have questioned the metabolic 
safety of liposuction and suggested that the removal of SAT 
might be detrimental52 because it leads to an immediate 
increase in the proportion of total fat, which is VAT, and this 
phenomenon may worsen insulin resistance, lipid profile, 
and other cardiovascular risk factors.53 Corroborating this 
hypothesis, Weber et al54 reported increased insulinemia, 
triglyceridemia, and hepatic fat content in rats that were fed 
a hyperlipidic diet 3 months after lipectomy of SAT.
However, most studies in humans have failed to demon-
strate detrimental effects of liposuction on metabolism,4,51,53–63 
thus refuting the aforementioned hypothesis. Martínez-
Abundis et al56 demonstrated decreased leptin levels but no 
changes in insulin sensitivity in six obese, healthy women 
50 days after abdominal liposuction plus abdominoplasty. 
Mohammed et al57 evaluated seven obese women at 10, 27, 
and 208 weeks following a large-volume liposuction. As 
expected, the authors observed a 25% decrease in SAT but 
no changes in VAT, lipid profile, and insulin sensitivity at 
any time point. Busetto et al55 observed lower levels of leptin 
but no changes in resistin, IL-6, TNF-α, and FFA levels at 
28 days and 6 months after surgery in eight morbidly obese 
diabetic or glucose-intolerant subjects. An improvement in 
insulin sensitivity was observed 28 days after surgery, but it 
was no longer significant after 6 months. Klein et al58 studied   
15 women with central obesity (waist circumference .100 cm), 
of which eight demonstrated normal glucose tolerance and 
seven had type 2 diabetes. Three months after a large-volume 
abdominal liposuction, despite the reduction in body weight, 
abdominal and body fat mass, and leptin levels, there was 
no change in insulin sensitivity. In addition, there were no 
changes in fasting glycemia; in TNF-α, IL-6, adiponectin,   
and CRP levels; or in cardiovascular risk factors such as blood 
pressure and lipid profile. The authors stated that liposuction Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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should not be considered as a clinical treatment for obesity, 
because it does not appear to have beneficial effects on the 
metabolic profile due to the decreases in body weight and 
body fat induced by diet and exercise. It must be noted that 
exercise- or diet-induced loss of body weight and body fat leads 
to a decrease in both SAT and VAT,38 which is associated with 
cardiovascular risk factors. In fact, experimental studies have 
shown that the surgical removal of VAT is associated with an 
immediate improvement of insulin resistance,64 thus validating 
the benefits of reducing fat stored in this depot.
As described previously, and similarly to VAT, deep 
abdominal SAT is also strongly related to insulin resistance 
and other cardiovascular risk factors.38 Up to 50% of SAT is 
located in the deep layer and, during abdominal liposuction, 
this is the predominant removed tissue.50,51 Corroborating 
this hypothesis, the aforementioned studies reported no 
changes,55–58 and many other studies have reported improve-
ments in one or more cardiovascular risk factors 3 weeks to 
6 months after liposuction.4,51,53,59–63
Davis et al51 evaluated the effects of small-volume abdom-
inal liposuction in 15 normal to overweight healthy women. 
One month after surgery, no changes in leptin, adiponectin, 
IL-6, and TNF-α levels were detected in either group. 
  However, there was a significant decrease in fast insulinemia 
in both groups, but only the obese group showed a signifi-
cant improvement in insulin sensitivity. Six months after a 
small-volume abdominal liposuction in 30 healthy obese 
women, Giugliano et al60 observed improved insulin sensi-
tivity; diminished levels of IL-6, IL-18, TNF-α, and CRP; 
and increased levels of adiponectin and   HDL-cholesterol in 
the absence of weight loss.   Robles-Cervantes et al59 dem-
onstrated no changes in body weight, fasting insulinemia, 
and insulin sensitivity measured by homeostasis model 
  assessment-insulin resistance (HOMA-IR) at 21 days after 
a small-volume abdominal liposuction in 15 healthy normal-
weight women. However, a decrease in fasting glycemia, total 
cholesterol levels, and estimated insulin secretion measured 
by HOMA% was observed. Fasting glycemia was reduced 
and insulin sensitivity was improved 1 month after a large-
volume liposuction in 12 healthy obese women.61 D´Andrea 
et al4 reported improved insulin sensitivity; reduced levels 
of fasting insulin, glucose, TAGs, total cholesterol, leptin, 
TNF-α, resistin, and IL-6; reduced blood pressure; and 
increased adiponectin levels in 123 healthy obese women at 
90 days after a large-volume liposuction. Insulin sensitiv-
ity was improved, but no changes in the lipid profile were 
detected at 4 months after a large-volume liposuction in 14 
healthy overweight to obese women.53 On the other hand, 
Ybarra et al62 demonstrated an improved lipid profile but 
no changes in insulin sensitivity or CRP and adiponectin 
levels in 18 healthy normal to slightly overweight women at 
4 months after a large-volume abdominal liposuction. Rizzo 
et al63 observed improved insulin sensitivity; decreased levels 
of IL-6, TNF-α, leptin, and resistin; and increased levels of 
IL-10 and adiponectin in 20 healthy obese women at 40 days 
after abdominal dermolipectomy. Finally, Hong et al65 
reported a significant improvement in the lipid profile but no 
changes in cytokine levels or insulin sensitivity at 2 months 
after surgery in 11 normal-weight healthy subjects.
Taken together, these studies have reported diverse yet 
mostly beneficial effects of liposuction on one or more 
cardiovascular risk factors (insulin sensitivity, lipid profile, 
and pro- and anti-inflammatory cytokines). Explanations 
for the diversity of these results may include differences 
in the follow-up time after surgery, in the methods used to 
test for insulin sensitivity, and mainly in the characteristics 
of the subjects. Most of the studies that evaluated morbidly 
obese people (BMI . 35 kg/m2) did not show significant 
improvements in the metabolic profile regardless of the 
follow-up time after surgery (50 days to 208 weeks).55,57,58 
One hypothesis is that the decrease in abdominal SAT, 
although substantial, may have been insufficient enough to 
overcome the negative effects of the excess visceral fat on 
insulin sensitivity, cytokine production, and lipid profile in 
these subjects. Consistent with this hypothesis, most studies 
evaluating overweight to slightly obese individuals observed 
significant improvements in insulin sensitivity4,51,53,59–61,63 and 
cytokine production,4,60,63 although they failed to observe 
improvements in the lipid profile,53,59,61 which indicated that 
the reduction of abdominal SAT in these subjects was effec-
tive in surpassing the effects of excess VAT on the metabolic 
profile. Finally, the few studies that evaluated normal-weight 
individuals did not demonstrate significant effects on the 
metabolic profile. In summary, these studies do not support a 
significant role for liposuction as a treatment for obesity and 
its comorbidities in morbidly obese subjects. Nevertheless, 
the results support the metabolic safety of liposuction for 
aesthetic purposes in normal to overweight or even slightly 
obese people, who represent the majority of people interested 
in this type of plastic surgery for cosmetic purposes.50
effects of liposuction on adiposity  
and body fat distribution
According to the “liposthatic theory” proposed by Kennedy,66 
a long-term energy balance is achieved via accurate feedback 
systems that regulate adipose tissue depots. Thus, if total Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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body fat is constantly monitored, an instant decrease in body 
fat through liposuction could trigger feedback systems that 
might favor the recovery of body fat through a decrease in 
energy expenditure and/or an increase in energy intake.67
In many species, when body fat is surgically removed, 
it is recovered within a period of weeks to months,54,67–71 
  usually due to a compensatory adipose tissue expansion at 
intact depots54,68,69 rather than regrowth of the fat mass in 
aspirated depots.67 Many studies54,68–70 reported no visible 
regrowth of fat in the lipectomized depot but reported similar 
levels of total body fat in lipectomized and sham-operated 
wild-type or genetically obese animals as early as 30 days68 to 
1254 weeks to 16 weeks after lipectomy,69,70 which indicated 
that the lipectomized animals compensated for the removal 
of fat. In animal models, the ability of fat pads to exhibit 
compensation is not uniform and depends on the fat pad that 
is excised.54,69 In addition, the type of compensation may 
occur in a fat pad-specific manner.67,69,72 Internal fat depots 
appear to compensate via an increase in the size of fat cells 
(hypertrophy) and subcutaneous fat pads by an increase in the 
number of fat cells (hyperplasia). Giese et al53 emphasized 
the importance of evaluating a possible fat mass redistribu-
tion toward the visceral cavity after liposuction, which could 
enhance cardiovascular risk.
Most human studies have not assessed patients for 
regrowth or compensation of body fat after liposuction.67 
Nonetheless, the few studies that have made this attempt 
show controversial results. Rinomhota et al73 observed a 
substantial increase in body weight (+5%−6% of the pre-
surgery weight) and total body fat (+16% of the presurgery 
fat mass) in overweight to obese women 18 months after a 
large-volume liposuction plus abdominoplasty surgery. In 
contrast, 2 months after abdominal liposuction or abdomi-
noplasty in seven nonobese women, Lambert et al74 reported 
no changes in the regional fat distribution in nonoperated 
areas or in the fat cell size in femoral (nonoperated area) and 
abdominal regions (operated area). In addition, no changes 
were observed in food intake or resting energy expenditure 
(RER). Busetto et al55 also showed no evidence for adipose 
tissue regain or redistribution in obese women at 6 months 
after surgery, despite a decrease in RER and in leptin levels. 
Fat regain may have been detected in a longer-term follow-up. 
A period longer than 6 months may be necessary to induce 
substantial compensatory responses in humans, which differs 
from the findings reported for experimental studies, probably 
due to metabolic differences among species.
Leptin may be a major inducer of the possible com-
pensatory responses of adipose tissue at intact depots or 
regrowth of the fat mass at aspirated depots. Many studies 
have reported significant decreases in leptin levels as early 
as 1 day and up to 3 months after liposuction.4,55,58,63,75 This 
response is expected because SAT adipocytes, the primary 
source of leptin in humans,22,26 are removed during liposuc-
tion. As described earlier, leptin acts on hypothalamic neurons 
to inhibit food intake and to enhance energy expenditure 
and SNS activity.23 It also has peripheral effects, such as 
increased lipolysis and elevated glucose and FFA oxidation 
in skeletal muscle.22,24,25 Thus, the instant decrease in leptin 
levels after liposuction could trigger compensatory responses 
that enhance food intake and decrease energy expenditure, 
which would facilitate weight and fat regain. However, it is 
important to emphasize that leptin is not likely to be the only 
substance that affects the regulation of body fat, as serum fac-
tors other than leptin also appear to stimulate adipogenesis,69 
and compensatory responses of fat have been reported in rats 
carrying a leptin receptor deficiency.70
Nevertheless, it is logical to expect a positive energy 
balance if there is any compensatory growth of adipose 
tissue following liposuction. Decreases in body weight and 
fat through caloric restriction lead to a decrease in the RER 
and an enhancement in appetite and metabolic efficiency that 
might help reverse weight and fat loss in humans74,76 and in 
experimental studies.77–79 Thus, it would be expected that the 
observed recovery of body fat after lipectomy in experimental 
studies could be facilitated by the same mechanisms. Animal 
experiments show that lipectomy does not lead to increases 
in food intake.54,67,69,79 Thus, it is likely that decreases in 
energy expenditure and/or increases in metabolic efficiency 
may provide the extra energy needed for compensatory fat 
deposition in animals after lipectomy.67,77 Previous studies 
in nonobese women who underwent either large- or small-
volume liposuction53,74 support an absence of RER or changes 
in metabolic efficiency after liposuction in this population, 
in contrast to the results reported for obese subjects.55 There 
is evidence that the fat-free mass is the major determinant 
of the resting metabolic rate, whereas the fat mass is a sig-
nificant factor only in obese subjects.80 Thus, obese subjects 
may present stronger adaptive responses that favor body fat 
regain after liposuction through the decrease of RER.
It has been affirmed that presurgery body fat is an impor-
tant factor in determining weight and fat gain following 
surgery and that overweight and obese individuals are more 
prone to the recovery of body fat than eutrophic people,68,73 
although to our knowledge no studies have directly addressed 
this issue. Nevertheless, Rinomhota et al73 reported greater 
weight and body fat regain in subjects with a higher   presurgery Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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weight at 18 months after a large-volume   liposuction plus 
abdominoplasty surgery. Experimental   studies seem to sup-
port this hypothesis. Harris et al70 reported that all intact fat 
pads tended to increase at 16 weeks after lipectomy in wild-
type and ob/ob obese mice, which might have accounted for 
the recovery of total body fat in both genotypes; however, 
this difference only reached significance for the visceral fat 
pads in the obese mice. Bueno et al68 reported a significant 
increase in the carcass lipogenesis rate and in the percentage 
of small-area adipocytes at the site of fat removal at 30 days 
after lipectomy of retroperitoneal and epididymal fat pads 
in monosodium-glutamate obese animals but not in control 
animals. The authors suggested that the increased metabolic 
efficiency observed in these animals stimulated the differ-
entiation of adipocytes, thus favoring reposition of the lost 
adipocytes and restoration of the fat pad removed.
Exercise
effects of exercise on the metabolic 
profile
Physiologic changes occur to increase lipid utilization dur-
ing exercise. Enhanced sympathetic activity increases cat-
echolamine levels, which activate HSL via b-adrenoreceptor 
stimulation and suppress insulin, reducing its inhibitory 
effects on HSL.5 These changes stimulate lipolysis and 
consequently lead to increased glycerol and circulating 
levels of FFAs, which may be used as substrates for energy 
production.81 In addition, an increase in the catecholamine-
stimulated lipolytic responsiveness of adipocytes seems to 
occur, which further increases lipid mobilization during 
exercise.82,83
During low- to moderate-intensity exercise (40%–65% 
VO2max), lipids are the predominant source of energy.82 
Nevertheless, during high-intensity exercise, lactate accumu-
lation inhibits HSL activity and thus reduces the mobilization 
of adipocyte lipids and favors the use of glucose and glycogen 
as sources of energy production in muscle.84
Chronic exercise training also results in the follow-
ing physiologic adaptations that enhance lipid utilization 
  during exercise: i) higher intramuscular TAG hydrolysis,85 
ii) a higher lipolytic capacity of adipocytes in response to 
increased levels of catecholamine due to a greater effi-
ciency or stimulation of the b-adrenergic pathway and a 
diminished inhibition of lipolysis by α-adrenoreceptors,5 
and iii) an increased proportion of energy derived from FA 
oxidation during exercise82 due to an enhanced muscle lipid 
oxidation capacity.83 The latter adaptation is facilitated 
by increased capacities for FA uptake by muscle cells, 
which is likely due to the higher contents of membrane 
FA transport proteins such as FA-binding protein and 
FA translocase (CD36) and subsequent mitochondrial 
transport and b-oxidation, probably caused by a higher 
content of the mitochondrial transporter carnitine palmi-
toyltransferase I.86
It has been established that exercise acutely improves glu-
cose uptake via increased insulin sensitivity and via muscle 
contraction in an insulin-independent manner. Both mecha-
nisms have additive effects and stimulate glucose uptake 
via separate pathways.87,88 Muscle contraction stimulates 
glucose uptake through the following proposed mechanisms: 
increased release of Ca2+ from the sarcoplasmic reticulum, 
which results in the activation of Ca2+/calmodulin-dependent 
protein kinase II (CaMKII); activation of the adenosine 
monophosphate (AMP)-activated protein kinase pathway 
(AMPK) due to a decrease in adenosine triphosphate and 
an increase in AMP; activation of mitogen-activated protein 
kinase 38;87,89 and phosphorylation of Akt/protein kinase B.90 
These mechanisms will ultimately increase the transloca-
tion of GLUT-4 from intrasarcolemmal pools/vesicles to 
the cell surface91 via a mechanism(s) that is not completely 
understood. Therefore, the immediate effects of exercise on 
glucose uptake appear to rely primarily on increased GLUT-4 
trafficking.90 In addition, it has been suggested that insulin 
sensitivity remains elevated immediately after exercise, thus 
improving glucose uptake in an insulin-dependent manner for 
up to 48 hours after exercise cessation.90 This phenomenon is 
probably due to a higher and more responsive translocation 
of GLUT-4 to the cell surface87,91 and to endurance exercise-
induced glycogen depletion.87
Exercise training also improves glucose uptake via 
insulin-mediated mechanisms, thus enhancing insulin sen-
sitivity and activity.87,90 The enhanced activity of insulin 
after exercise training may be associated with the following: 
i) increased expression of GLUT-4 mRNA and protein in 
skeletal muscle;87 ii) enhanced postreceptor insulin signal-
ing at the level of phosphatidylinositol-3-kinase activity, 
which may lead to enhanced GLUT-4 translocation;91 
iii)   upregulation of AMPK activity, which enhances glucose 
uptake and stimulates FA oxidation;90 and iv) increased 
oxidative capacity of skeletal muscle via upregulation of 
the proteins involved in mitochondrial biogenesis, such as 
PPARγ coactivator.92 It has been suggested that enhanced 
whole-body lipid oxidation is a strong predictor of insulin 
sensitivity.93 Thus, if exercise training increases the propor-
tion of lipids targeted for oxidation,82 it will ultimately lead 
to improved insulin sensitivity.33Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 submit your manuscript | www.dovepress.com
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Exercise may also affect insulin indirectly through its 
effects on adipokines and inflammatory cytokines.   However, 
in general, studies investigating the effects of exercise train-
ing on adipokine and cytokine levels and expression are quite 
controversial.
The majority of studies have reported either no change31,94–96 
or a reduction in leptin levels97–102 after chronic exercise train-
ing, and these results have been attributed primarily to the 
capacity of exercise to induce a loss of fat mass.97,98,100,102 
Conversely, a few studies have demonstrated a reduction in 
leptin levels and/or expression regardless of any changes in 
adiposity.99,101 These results suggest that there may be factors 
beyond adiposity that regulate leptin levels and expression 
after endurance training, among which adipokines are strong 
candidates. In addition, it has been proposed that regular 
exercise may lead to a “resetting” of leptin levels, such that a 
lower concentration of leptin can be maintained with a certain 
body fat content due to possible improvements of the activity 
and sensitivity of leptin in the hypothalamus.103
Studies on the effect of aerobic training on plasma adi-
ponectin have also showed conflicting results. Most studies 
have reported no changes in adiponectin levels,102,104–108 despite 
improved insulin sensitivity102,104,105,108 and changes in body 
weight,102,105–108 whereas other studies have demonstrated 
increased adiponectin levels and insulin sensitivity either with 
no changes in body weight109,110 or with weight loss.110–112 These 
heterogeneous results may be explained by the diversity of sub-
ject characteristics (body composition and metabolic profile) 
and the type of intervention used (exercise only or diet plus 
exercise). In addition, exercise intensity also appears to affect 
adiponectin in different ways.   Moderate-to-high-intensity 
aerobic or resistance exercise training appears to increase 
adiponectin levels, in contrast to low-intensity exercise, which 
suggests a dose-response   relationship.113 More importantly, 
many studies have shown that improvements in insulin 
sensitivity after exercise training may occur in the absence 
of changes in adiponectin.102,104,105,108,114 It is likely that the 
influence of other substances that are modified by exercise 
training and affect adiponectin synthesis and secretion, such 
as TNF-α and IL-6, may have different effects on adiponectin 
levels according to the type of intervention.102
The anti-inflammatory effects of exercise
It has been well established that several proinflammatory 
and anti-inflammatory cytokines increase markedly after 
exercise in a dose-response manner. The higher the duration, 
intensity, and amount of muscle mass recruited, the greater 
the increase.9,115 However, this increase differs from that of 
severe infections, in which the cytokine cascade consists of an 
initial increase in TNF-α and IL-1b followed by increases in 
IL-6, IL-1ra, aTNF-R, and IL-10.116 IL-6 is the first cytokine 
to increase in an exponential fashion (up to 100-fold) in 
response to exercise, followed by modest increases by one- to 
two-fold of TNF-α and IL-1.115,117 This inflammatory response 
is then counterbalanced by an increase in IL-1ra and IL-10, 
which are anti-inflammatory cytokines.117,118 As described 
earlier, IL-10 is a potent inhibitor of IL-1 and TNF-α pro-
duction, and it has been postulated that IL-10 is responsible 
for orchestrating the anti-inflammatory reaction.117 Studies 
have demonstrated that IL-6 is responsible for the increase 
in anti-inflammatory cytokines (IL-10 and IL-1ra) after exer-
cise, and it also inhibits the synthesis of TNF-α and IL-1,118 
thus inducing an anti-inflammatory milieu.9
It has been suggested that regular exercise training may 
exert a chronic anti-inflammatory effect that is potentially 
due to the repeated anti-inflammatory responses elicited 
by each acute bout of exercise.117 However, a link between 
the acute and chronic effects of exercise has not yet been 
established.
Epidemiologic studies have reported a negative asso-
ciation between the amount of regular physical activity 
and the levels of IL-69 and TNF-α.117 Interventional studies 
also support this relationship, although the results are less 
consistent.
A few studies have reported no changes in IL-6 and TNF-α 
levels after exercise training.102,104,106,109,112,119 The majority of 
studies, however, have reported a decrease in IL-6,111,120–122 
TNF-α,123–125 or both.126–128 It has been proposed that a weight 
loss of 10% is associated with a marked improvement in the 
metabolic abnormalities associated with obesity, including 
circulating inflammatory markers.8 In addition, overweight to 
obese people may present low-grade inflammation due to an 
excess fat mass126 and are likely to benefit more from weight 
loss compared with normal-weight subjects. Giannopoulou 
et al104 reported greater decreases in IL-6 levels in subjects 
who demonstrated the highest basal IL-6 levels. Most of the 
studies that reported decreased TNF-α and/or IL-6 levels after 
training evaluated overweight to obese people and used diet 
plus exercise as interventions.102,111,121,122,125–130 The weight 
losses in these studies were substantial (7%–15%), which 
might explain the positive results. If IL-6 and TNF-α are 
highly expressed and secreted from adipose tissue, weight loss 
and fat mass loss would lead to significant decreases in these 
cytokine levels. The isolated effects of exercise, however, 
are much less consistent. Only a few studies have evaluated 
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of IL-6 and TNF-α,104,109,123,124 and all but one119 evaluated 
overweight to obese subjects. These studies reported a weight 
loss that did not exceed 5% (3 kg), which is expected because 
exercise training per se does not induce a considerable energy 
deficit that could lead to substantial weight loss.131 The lack of 
significant weight loss in these studies and the different types 
of exercise used may explain the inconsistent results. Four 
studies reported no change,102,104,119 and two studies reported 
a decrease in TNF-α levels.123,124 Thus, the combination of 
exercise training and a hypocaloric diet shows more consistent 
results for the reduction of markers of inflammation than does 
exercise or even diet alone in overweight to obese subjects. 
However, the independent effect of exercise training on 
cytokine production from different cell types within adipose 
tissue requires further investigation.114
To our knowledge, no studies in humans have evaluated 
the effects of exercise on IL-10 levels. However, one experi-
mental study has recently demonstrated that the mesenteric 
adipose tissue of endurance-trained rats showed an increase in 
TNF-α content and an even greater increase in IL-10 content 
in comparison with sedentary rats.37 The authors suggested 
that increased TNF-α is likely to function as a modulator of 
lipid metabolism by increasing lipolysis in adjacent tissues 
and that increased IL-10 may block the potentially deleterious 
inflammatory effects caused by TNF-α. Thus, the increased 
IL-10/TNF-α ratio after exercise training may favor the onset 
of an anti-inflammatory environment in adipose tissue, which 
represents one of the possible mechanisms through which 
exercise may exert its anti-inflammatory effects.
Future studies should evaluate the effects of exercise 
training with or without dieting on proinflammatory and anti-
inflammatory levels to determine the inflammatory balance 
rather than the inflammatory cytokine status alone. Even in 
the absence of changes in proinflammatory cytokines, an 
increase in anti-inflammatory cytokine levels may result in an 
anti-inflammatory environment. Costa Rosa132 has elegantly 
suggested the use of “exercise as a complementary strategy 
in the treatment of chronic diseases”, corroborating the find-
ing that regular exercise appears to protect against diseases 
associated with low-grade systemic inflammation, such as 
most chronic diseases.8
effects of exercise on body  
fat distribution
Previous studies have consistently shown that without any 
dietary restrictions, exercise training has a modest effect 
on weight and fat loss,6,7,133–135 whereas resistance exercise 
training may even induce increases in body weight through 
elevations in the fat-free mass.7,134,135 One exercise session 
with a duration of 60–90 minutes will lead to the oxidation 
of a very small amount of fat (approximately 50–75 g at the 
most), which has an obviously feeble effect on weight loss.81 
However, if energy intake remains stable, aerobic exercise 
training could have a substantial effect on adiposity over a 
prolonged period.81 Furthermore, there seems to be a pref-
erential reduction in VAT and abdominal SAT rather than 
changes in gluteofemoral SAT136,137 in response to exercise 
training-induced weight loss. Although it is clear that a 
greater amount of weight results in the reduction of more 
visceral fat, even in the absence of weight loss,138–141 exercise 
training may lead to significant reductions in VAT.
As described earlier, the capacity for TAG mobilization of 
adipose tissue varies according to its location.6,17 Abdominal 
adipocytes, especially visceral adipocytes, are more sensi-
tive and responsive to the lipolytic effect of catecholamines 
than gluteofemoral SAT5 due to the number and sensitiv-
ity of b- and α-adrenoreceptors. Thus, because exercise 
greatly enhances sympathetic-induced catecholamine levels, 
repeated bouts of exercise could lead to consistent, preferen-
tial lipid mobilization in abdominal adipose tissue, especially 
VAT, as opposed to gluteofemoral SAT, thus resulting in 
decreased abdominal fat and sustained SAT.6,133
Epidemiologic studies have demonstrated an inverse 
relationship between training status and the degree of 
upper-body fat.5,140 More importantly, evidence from inter-
ventional studies support exercise as an effective interven-
tion for reducing abdominal fat, especially visceral fat, in 
overweight or obese individuals.140 However, it is important 
to note that pretraining weight is a strong determinant of 
exercise-induced changes in abdominal fat,6 as most studies 
have reported a reduction of abdominal fat in overweight 
and obese subjects but not in nonobese subjects.140 Thus, if 
excess upper-body fat, especially in the visceral region, has 
a greater association with several cardiovascular risk factors 
and diseases compared with excess lower-body fat,17,41,42,44,45 
exercise training may be considered a very important non-
pharmacologic treatment for obesity, in part by altering the 
distribution of body fat toward lower-body regions.
Liposuction and exercise training
Liposuction and exercise appear to directly affect metabo-
lism in similar ways, which suggests a possible interaction 
between these two strategies. Nevertheless, there is one 
main difference between them: liposuction surgery decreases 
SAT exclusively, whereas exercise training enhances lipid 
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immediate liposuction-induced increase in the VAT/SAT 
ratio might be detrimental to metabolism,53 exercise training 
might be a prime strategy to block or reverse these possible 
deleterious effects due to its ability to reduce VAT.5,6
However, the aforementioned hypothesis is very unlikely 
because most studies in humans have failed to demonstrate 
detrimental effects of liposuction on metabolism.4,51,53,55–63 
During liposuction, not only the abdominal superficial SAT 
layer but also the deep SAT layer is removed, and the latter is 
strongly related to insulin resistance and other cardiovascular 
risk factors.38 In accordance, most studies have reported either 
no change55–58 or improvements in one or more cardiovascular 
risk factors after liposuction.4,51,53,59–63 Therefore, in light of the 
positive effects on insulin sensitivity and the inflammatory bal-
ance, physical exercise training could have an additive or even 
a synergistic effect with liposuction on the metabolic profile.
Finally, animal studies have demonstrated that when body 
fat is surgically removed, it is recovered within a period of 
weeks to months,54,67–70 usually due to compensatory adipose 
tissue expansion at intact depots54,68,69 rather than regrowth of 
the fat mass at aspirated depots.67 According to the “lipost-
hatic theory” proposed by Kennedy,66 an instant decrease in 
body fat through liposuction could trigger feedback systems 
that might favor the recovery of body fat through a decrease 
in energy expenditure and/or an increase in energy intake. 
According to animal67,77 and human studies,55 it is likely that 
decreases in energy expenditure and/or increases in metabolic 
efficiency may provide the extra energy needed for com-
pensatory fat deposition following fat removal.67,77 Regular 
exercise training increases the total energy expenditure and 
preserves or even increases the fat-free mass,7 which could 
prevent the liposuction-induced decrease in energy expen-
diture and enhance lipid mobilization and oxidation.6 Thus, 
exercise training associated with liposuction could attenuate 
or even block the possible compensatory fat deposition in 
intact depots or regrowth of the fat mass.
To our knowledge, no human studies (and only one experi-
mental study) have attempted to evaluate the effects of lipo-
suction associated with exercise training.142 As expected, the 
authors reported that exercise training attenuated the increased 
lipogenesis rate and thus impaired the restoration of adipose 
tissue observed in lipectomized sedentary animals. Further 
studies are necessary to confirm these results in humans.
Conclusion
Liposuction is the most popular aesthetic surgery performed 
worldwide.47 In general, studies investigating the metabolic 
effects of liposuction are controversial, and most of the   studies 
performed in humans have reported either no change55–58 
or improvements in one or more cardiovascular risk 
factors.4,51,53,59–63 In addition, animal studies have shown that 
when body fat is surgically removed, it is recovered within a 
period of weeks to months,54,67–70 but the few studies performed 
in humans have demonstrated inconsistent results.
Chronic exercise training induces physiologic adapta-
tions that enhance lipid oxidation during exercise and 
improve insulin sensitivity and inflammatory balance. It also 
results in an increased total energy expenditure, a preserved 
or increased fat-free mass,7 and reduced abdominal fat,6 espe-
cially visceral fat, in overweight or obese individuals.140
Thus, one could suggest that the association of exercise 
training with liposuction could, first, attenuate or even block 
the possible liposuction-induced compensatory fat deposi-
tion in intact depots or regrowth of the fat mass and, second, 
exert an additive or even a synergistic effect with liposuction, 
improving insulin sensitivity and the inflammatory balance, 
which would lead to an improvement of cardiovascular risk 
factors.
Thus, one could suggest that liposuction and exercise 
are safe and effective strategies for fat loss that could be 
associated with better results either for aesthetic purposes 
or for the treatment of metabolic disorders. Furthermore, 
studies in humans regarding the interaction of these two fat 
loss interventions on metabolism and adiposity are needed 
to confirm the positive effects of exercise reported in animals 
after partial lipectomy.142
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